FOOYA! is a gamified medical mobile App for children and young adults based on the pioneering digital vaccine platform developed by Friends Learn, which is a Silicon Valley and Chennai based research translation and innovation partner of the Digital Vaccine Project at Carnegie Mellon University. It is a product of fundamental breakthroughs in neurocognitive computing and neuro-behaviour-physiological modulation through gamified immersive mobile virtual reality (VR) based neurocognitive training, to prevent metabolic diseases such as diabetes, hypertension, cardiovascular disease and certain types of Cancer. It works non-invasively by stimulating biological mechanistic pathways in the gut-brain axes, as well as through the immune system, through VR based gamified experiential neurocognitive training and implicit learning models.
FOOYA! Was featured as a case study of cutting edge research at the 2018 SBCC Conference by Johns Hopkins University Bloomberg School of Public Health, UNICEF, and BBC Action. It delivers a unique health education curriculum, which is made available through select accredited school partners, in India and around the world, to protect the health of children and their families through clinically proven, safe, and ethically developed scientific innovation.
CCC-I collaborated with this world-leading consortium of researchers from Carnegie Mellon University, Hofstra University and Johns Hopkins University Bloomberg School of Public Health. Results from the randomized controlled field trial designed and undertaken by CCC-I researchers in a school setting have been published in the top peer-reviewed journal for digital medicine - JMIR mHealth and uHealth. The team found statistically significant evidence of positive neuro-behavior health outcomes in children caused by the first 20-minute dose exposure. The research team also found a strong effect sustained as a result of a booster dose after a week. No harmful side effects were reported during the study and during follow-ups.